Difference between revisions of "CEBPA-AS1"

From LncRNAWiki
Jump to: navigation, search
(→‎Name)
 
(2 intermediate revisions by one other user not shown)
Line 2: Line 2:
 
==Annotated Information==
 
==Annotated Information==
 
===Name===
 
===Name===
−
CEBPA-AS1:CEBPA antisense RNA 1 (head to head)
+
Approved symbol: ''CEBPA-DT''
 +
 
 +
Approved name: ''CEBPA-DT'' : CEBPA divergent transcript
 +
 
 +
Previous symbols：CEBPA-AS1
 +
 
 +
Previous names：CEBPA-AS1: CEBPA antisense RNA 1 (head to head)
 +
 
 +
HGNC ID: HGNC: 25710
 +
 
 +
Ensembl ID: ENSG00000267296
 +
 
 +
RefSeq ID：NR_026887
 +
 
 +
LncBook ID: HSALNT0288913
  
 
===Characteristics===
 
===Characteristics===
−
CEBPA-AS1 is the antisense RNAs of CEBPA.<ref name="ref1" />
+
CEBPA-AS1 is the antisense RNAs of CEBPA <ref name="ref1" />.
  
 +
===Function===
 +
CEBPA-AS1 is enriched in human gastric cancer tissues and significantly elevated in the plasma of patients with gastric cancer. This result indicates that CEBPA-AS1 might be used as diagnostic or prognostic markers for gastric cancer patients <ref name="ref1" />.
  
 
===Diseases===
 
===Diseases===
 
Gastric cancer <ref name="ref1" />
 
Gastric cancer <ref name="ref1" />
 +
 
===Expression===
 
===Expression===
−
The expression of CEBPA-AS1 is decreased in Gastric cancer (GC） tissues, And the expression levels of CEBPA-AS1 is associated with tumor grade.<ref name="ref1" />
+
CEBPA-AS1 is up-regulated in both gastric cancer (GC）tissues and plasma of patients with gastric cancer, and the expression levels of CEBPA-AS1 is associated with tumor grade <ref name="ref1" />.
  
 
===Sequence===
 
===Sequence===

Latest revision as of 02:58, 31 July 2019

Annotated Information

Name

Approved symbol: CEBPA-DT

Approved name: CEBPA-DT : CEBPA divergent transcript

Previous symbols：CEBPA-AS1

Previous names：CEBPA-AS1: CEBPA antisense RNA 1 (head to head)

HGNC ID: HGNC: 25710

Ensembl ID: ENSG00000267296

RefSeq ID：NR_026887

LncBook ID: HSALNT0288913

Characteristics

CEBPA-AS1 is the antisense RNAs of CEBPA [1].

Function

CEBPA-AS1 is enriched in human gastric cancer tissues and significantly elevated in the plasma of patients with gastric cancer. This result indicates that CEBPA-AS1 might be used as diagnostic or prognostic markers for gastric cancer patients [1].

Diseases

Gastric cancer [1]

Expression

CEBPA-AS1 is up-regulated in both gastric cancer (GC）tissues and plasma of patients with gastric cancer, and the expression levels of CEBPA-AS1 is associated with tumor grade [1].

Sequence

>NR_026887.1 Homo sapiens CEBPA antisense RNA 1 (head to head) (CEBPA-AS1), long non-coding RNA

000001 CACGGCCGGG AGCCCAGGAG TATCCCGAGG CTGCACGGGG TAGGGGTGGG GGGCGGAGGG CGAGTCTTGG TCTTGAGCTG 000080
000081 CTGGGGCGCG GATTCTCTTT CAAAGCCAGA ACCAGGCCTG TCCCGGACCC GCGTCCCGGG GAGGCTGCAG CGCAGAGCAG 000160
000161 CGGGGCTGGG GCCGGTGGGG GGCCGTTTGG GACGCGCGGA GAGGTCCTGA GCGCGGTGGC TCTGCGTCTC CTAGCTCTGA 000240
000241 TCTCCAGGCT ACCCCTGTGA TTCCGCGCAG AGGTACCTCT CGGAGGACGC CGGGGTCCCA TGGGCGGCGC CGCGCAGGGC 000320
000321 GCTAGGACCC CGCGGGGAGC GGAGGCGGCC TCGGCCCGGG AGCCTGGAGG ACCTGGCCGG TCGATCCGCC CGGGCTGGAA 000400
000401 AACTTTCTTT ATAATTACTT CTCCAGGTCG GAGCGCGCGG CTTGCTAGGC GCGCGGGGCC GGCGCTGTTA CCCGGCGTGG 000480
000481 AGTCGCCGAT TTTTTTTCCT GCGGGACCGC GGGGCCCCCC AGACTAGCGG AGCTGGACGC CGGGGCGAGC ACGGGGAGGG 000560
000561 GCGCACCGAG GGAGGAGACA AACTTAACTC TGGGGCCGGG ATTCCGAGGC GGGGGCCGCA GCCCTCGAGG CCCGAAGCCA 000640
000641 CCGCTTCCTC CCCCGCCTCC CCATTCAGGT GGGCGCCAAC GGCGGGAGCG AGGGTGTCCA GGCCGCCGGG CTGCCAGGTC 000720
000721 CGAGCACGCA CAGGGAGAAC TCTGCCCAGT GGTTCGCCGG GCGCTGTAGT CCCCGGGATC CTAGGGACCG AGGCGGCCAG 000800
000801 GCCCTGGGGC CCCTTGAGTG CGGCAGCTAA TGCTCTCACC GCGGCGGGGG AAGGAGCTTG CCACCGAGAC CCCCAGCCAC 000880
000881 GTGCGTCCCT CGCATTCTTT ACCGGGGCCG GGGTGGCGGC TACGGACCGT CAGCTGGGCC CAGATGGAGT CTTGGGAGCC 000960
000961 CTCAAGTGTC TCCTGTCCTT GCCCGCGCCG CCCCTCGCCA CTGGCGCTGA GGCCTGACGC CGCCTGCGTC CCGGCTAGAG 001040
001041 GCGCGCTTGC CTACAGGTGA GGGAAGACCC CCTTCACCGA CAGTGGCCTT AGGCCTGGCA AGGCGCCACG ACCCGCCCAG 001120
001121 GAGCCCCGGA GGGGGCACAG CTAAAAACAC CGCTGGAGAG CCCCGAGCTT CCACGACGAT CGCAGTAAAG AAGCAGTTTC 001200
001201 ATCTGGGCAA CGCACACTGC GCTTTAATCA AGTTCCTATT CAACATAGTC CCAGTGATTA ATAGCCCAAC TGCTTCGTTT 001280
001281 TCGGTCCAGA GCTCATAAAC AAGATATTTT TAGCTTGACG CTTTTGGACG GGAGGGAGTA AAAACCAGAT ACGTTAAATA 001360
001361 AATATCCCGA TGTGAGCCGG AGAGCTGCTT GCTGAGCCAA ATGCAGGACC CATTCATATA GCATTCACCT GTGGAGGGAG 001440
001441 ACCTGGACGG AAATCAAAAA GCACCAAGAG CGATTTGCGT TTTTTTCTGC GGTGCTAAAA CTAATGGCTT TTCCTACCTA 001520
001521 GGAACAAAGA AACGCCACTG TACATGCACG GTTCCCGGCC TGTGGAGTTG TGGGAGGAAG GCGATGTCTG GCCTTTTTTG 001600
001601 CACAGCTGCT GTTGCCTGCC CAGAGATCGG GAACTCTGCC CCGTAGGACT GGAAGAAACC TCAGTAATGG GAATAAGACT 001680
001681 TTGTCCAATA GGGGGCTGAT GAATGTGTGG GGGCGACAAT GGCAAGGAGT GGGACTCCCG GCCCGGGGTT CGCCAACCCC 001760
001761 AGGGGCCACA GGTCCTCCTA CAATTGAACC AGAATTCACC CACCCGGGCC TGCCCTGTGC AGGGTGCCGA GAGCCCAGGG 001840
001841 ATGCATGAGA GGGTGGCTCC TGCCTCTGGG AACTGGGACA GTGGGAGAGA CGGATAAGTT GTCACACAGA GGCTGCTGGG 001920
001921 AGGAAGGAGG AGACAGAAGG AGTAGGGGAT GGGACTTCAT TCATTCATCA AATGCACACG AGGCACAAAT GGGAATCAAG 002000
002001 GGTGGATGTG CTGTGATGAA GAGAAGTCCT GCCCTGAACA AGGTGGCGCT GTGGAGGAGG CAGAGATCAG ATTTGTCTGC 002080
002081 GGAGGTGTTA TGGACTGAAC TGTGTCCCTG CCCCAAATTC CTATGTTGAA GGCCTAACCC CCATGTGACT GTATTTGGAG 002160
002161 ATAAGGCTTT TAGGAAGTCA TTAAAGTGAG ATGATGTCAT AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA 002240
002241 AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA A

Labs working on this lncRNA

  • General Surgery, The Second Hospital of Jilin University, Changchun, 130041, China.

References

  1. ↑ 1.0 1.1 1.2 1.3 Ke D, Li H, Zhang Y, An Y, Fu H, Fang X, Zheng X. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer. Oncotarget. 2017 Mar 28;8(13):21516-21525.
Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=CEBPA-AS1&oldid=1276025"